Drs. David Baltimore, Owen Witte, and Lili Yang jointly receive a $1M GTSN Challenge Award for Lethal Prostate Cancer from the Prostate Cancer Foundation (PCF), to study T cell receptor gene therapy for treatment of lethal prostate cancer.
Drs. David Baltimore, Owen Witte, and Lili Yang jointly receive a $1M GTSN Challenge Award for Lethal Prostate Cancer from the Prostate Cancer Foundation (PCF), to study T cell receptor gene therapy for treatment of lethal prostate cancer.